Automated insulin delivery (artificial pancreas systems) and also digitally enhanced technologies for multiple-daily insulin administration, such as smart pens in combination with continuous glucose monitoring, are arising as cost-effective solutions in type 2 diabetes management [80]. Here, INS is linked to type 2 diabetes mellitus.